Sell; Under; Hold; Over; Buy. Number of Ratings 8 Full Ratings. Recent News. MarketWatch. Dow Jones. Aquestive Therapeutics started at neutral with $3 stock. A stock's price target is the price at which analysts Analysts typically set price targets that correspond to their buy or sell recommendations. So Aquestive Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's. Aquestive Therapeutics (NASDAQ:AQST) Stock, Analyst Ratings, Price Targets, Forecasts Aquestive Therapeutics Inc has a consensus price target of $ based. Should I Buy Aquestive Therapeutics Inc Stock? Overall, Aquestive Therapeutics Inc stock has a Growth Grade of D, Momentum Grade of A. Whether or not you.
AQST Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Negative shareholders equity · Currently. Aquestive Therapeutics has received a consensus rating of Buy. The company's average rating score is , and is based on 6 buy ratings, no hold ratings. Aquestive Therapeutics currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the. Real time Aquestive Therapeutics (AQST) stock price quote, stock graph, news & analysis Sell My Personal Information. Current. We Care About Your Privacy. We. Track Aquestive Therapeutics Inc (AQST) Stock Price, Quote, latest community messages, chart, news and other stock related information Do Not Sell or Share My. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with. View Aquestive Therapeutics, Inc. AQST stock quote prices, financial information, real-time forecasts, and company news from CNN. Andreas Argyrides, a top 13% analyst from Wedbush maintains AQST with a buy rating and raises their AQST price target from $ to $, on Mar 7, Sell. 0. 0. 0. Consensus. Buy. Buy. Buy. Overview · Research & Ratings. Notes & Data Providers. Stocks: Real-time U.S. stock quotes reflect trades reported. Research Analysis: AQST. View More. Earnings Per Share. Consensus EPS. Analyst Recommendations. Strong Buy. Buy. Hold. Underperform. Sell. Analyst Price Targets. Barchart Opinion ; 50 - Day MACD Oscillator, Buy ; 50 - Day Average Volume: 1,,, Average: 50% Sell ; Long Term Indicators ; Day Moving Average, Sell.
View the real-time AQST price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a. Is Aquestive Therapeutics stock a Buy, Sell or Hold? Aquestive Therapeutics stock has received a consensus rating of buy. The average rating score is and is. Buy. Buy. Hold. Sell. Strong Sell. About Aquestive Therapeutics Inc. Sector. Health Care. Industry. Pharmaceuticals How do I buy Aquestive Therapeutics (AQST). Analyst Consensus. Strong Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. AQST Sentiment % Sector Average 68% ; Hedge Fund. Buy. 6. 8. 7. Overweight. 1. 1. 1. Hold. 0. 0. 0. Underweight. 0. 0. 0. Sell. 0. 0. 0. ConsensusBuyBuyBuy. Stock Price Target. High, $ Low, $ Average. According to analysts, AQST price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Analyst Ratings. The average analyst rating for AQST stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to. Buy AQST Stock. See AQST stock price and Buy/Sell Aquestive Therapeutics Inc. Discuss news and analysts' price predictions with the investor community. Start.
AQST Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Negative shareholders equity · Currently. There are currently 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AQST shares. Based on analysts offering 12 month price targets for AQST in the last 3 months. The average price target is $ with a high estimate of $13 and a low. $ (% upside). Analyst Consensus: Strong Buy. Created with Highcharts Strong Sell Sell Hold Buy Strong Buy 0 2 4 6. Stock Forecasts. AQST, CENTA and RAMP have been added to the Zacks Rank #5 (Strong Sell) List on July 11,
Thinking of buying or selling Aquestive Therapeutics Inc stock that's listed in a currency different from your local one? Use our international stock ticker. AQST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where. USA. Stock. Aquestive Therapeutics. Aquestive Therapeutics Investment Advice. AQST Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what. Get Wall Street analysts ratings for Aquestive Therapeutics, Inc. (AQST). Buy or Sell this stock? See what the analysts say. Is AQST a Buy, Sell or Hold? Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. Recent News. Aquestive Therapeutics (NASDAQ:AQST) Stock, Insider Trading Activity. Aquestive Therapeutics: Insider buying and selling updated today. What is Insider. AQST is UP 52% since the begininning of the year ; AQST is DOWN -5% BELOW 20 day SMA ; AQST is UP 17% ABOVE day SMA.